Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
Jordi Riba, Antoni Rodrı́guez-fornells, Gloria Urbano, Adelaida Morte, Rosa María Antonijoan, María Jesús Miranda Montero, J. C. Callaway, Manel J. Barbanoj
Psychopharmacology February 22, 2001 DOI: 10.1007/s002130000606 via OpenAlex
Summary
AI-generated from the abstractAyahuasca, a South American psychoactive beverage containing DMT, produced dose-dependent psychological effects in six healthy male volunteers with prior experience. Encapsulated freeze-dried ayahuasca at doses of 0.5, 0.75, and 1.0 mg DMT/kg body weight increased scores on hallucinogen rating scales, addiction research inventory scales, and visual analogue scales for liking, good effects, and high. Effects began within 30-60 minutes, peaked at 60-120 minutes, and resolved by 240 minutes. The tea was well tolerated cardiovascularly, though nausea and altered physical sensations were common. Five volunteers found the experience pleasant; one had an intensely dysphoric reaction with anxiety and withdrew. Ayahuasca induced perceptual, affective, cognitive, and somatic changes of longer duration and milder intensity than intravenous DMT.
Study at a glance
| Characteristics | Single-blind crossover placebo-controlled clinical trial Peer reviewed |
|---|---|
| Sample size | 6 |
| Population | Healthy male volunteers with prior experience using ayahuasca |
| Intervention | encapsulated freeze-dried ayahuasca |
| Dose | 0.5, 0.75, and 1.0 mg DMT/kg body weight |
| Topics | Anxiety Ayahuasca LSD Psilocybin |
| Keywords | Tolerability Hallucinogen Psychology |
| Citations | 302 |
| Key finding | Ayahuasca produced significant dose-dependent psychological effects, was generally well tolerated, and induced changes of longer duration and milder intensity than intravenous DMT. |
Abstract
RationaleAyahuasca is a South American psychoactive beverage that contains the naturally occurring psychedelic agent N,N-dimethyltryptamine (DMT). This "tea" has been used for centuries in religious and medicinal contexts in the rain forest areas of South America and is presently gaining the attention of psychedelic users in North America and Europe.ObjectivesIn the present study, the psychological effects and tolerability of ayvahuasca were assessed.MethodsThree increasing doses of encapsulated freeze-dried ayahuasca (0.5, 0.75, and 1.0 mg DMT/kg body weight) were administered to six healthy male volunteers with prior experience in the use of this tea, in a single-blind crossover placebo-controlled clinical trial.ResultsAyahuasca produced significant dose-dependent increases in five of the six subscales of the Hallucinogen Rating Scale, in the LSD, MBG, and A scales of the Addiction Research Center Inventory, and in the "liking", "good effects" and "high" visual analogue scales. Psychological effects were first noted after 30-60 min, peaked between 60-120 min, and were resolved by 240 min. The tea was well tolerated from a cardiovascular point of view, with a trend toward increase for systolic blood pressure. Modified physical sensations and nausea were the most frequently reported somatic-dysphoric effects. The overall experience was regarded as pleasant and satisfactory by five of the six volunteers, while one volunteer experienced an intensely dysphoric reaction with transient disorientation and anxiety at the medium dose and voluntarily withdrew from the study.ConclusionsAyahuasca can be described as inducing changes in the perceptual, affective, cognitive, and somatic spheres, with a combination of stimulatory and visual psychoactive effects of longer duration and milder intensity than those previously reported for intravenously administered DMT.